These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hallucinogenic substances. Their role in research and in current psychiatric therapy]. Benoit JC Sem Ther; 1965 Jan; 41(1):28-33. PubMed ID: 5879030 [No Abstract] [Full Text] [Related]
5. Hallucinogenic drugs. J Am Coll Health Assoc; 1965 Dec; 14(2):67-8. PubMed ID: 5841013 [No Abstract] [Full Text] [Related]
6. The pharmacology of the psychoactive drugs. Cohen S Northwest Med; 1966 Mar; 65(3):197-203. PubMed ID: 5907893 [No Abstract] [Full Text] [Related]
7. Hallucinogenic botanicals of America: a growing need for focused drug education and research. Halpern JH; Sewell RA Life Sci; 2005 Dec; 78(5):519-26. PubMed ID: 16188280 [TBL] [Abstract][Full Text] [Related]
8. 2,5-Dimethoxy-4-methyl-amphetamine: new hallucinogenic drug. Cabe PA Science; 1968 Mar; 159(3822):1491. PubMed ID: 5732494 [No Abstract] [Full Text] [Related]
9. The side effects of drugs. Böszörményi Z Int J Psychiatry; 1969 May; 7(5):294-6. PubMed ID: 5803744 [No Abstract] [Full Text] [Related]
10. Effect of marsilin on the behavioural and other changes in the central nervous system induced by psychotropic drugs. Dey PK; Chatterjee BK Indian J Exp Biol; 1966 Apr; 4(2):99-100. PubMed ID: 5942509 [No Abstract] [Full Text] [Related]
11. Neurochemical evidence that hallucinogenic drugs are 5-HT1c receptor agonists: what next? Sanders-Bush E NIDA Res Monogr; 1994; 146():203-13. PubMed ID: 8742800 [No Abstract] [Full Text] [Related]
12. Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. Aghajanian GK NIDA Res Monogr; 1994; 146():183-202. PubMed ID: 8742799 [No Abstract] [Full Text] [Related]
13. DMT at fifty. Szára S Neuropsychopharmacol Hung; 2007 Dec; 9(4):201-5. PubMed ID: 18510265 [TBL] [Abstract][Full Text] [Related]
15. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)]. Votava Z; Podvalová I; Vojtĕchovský M Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083 [No Abstract] [Full Text] [Related]
16. Frequency of hallucinogenic drug use and its implications. Fisher DD J Am Coll Health Assoc; 1967 Oct; 16(1):20-2. PubMed ID: 6052096 [No Abstract] [Full Text] [Related]
17. A brief overview of the clinical pharmacology of "club drugs". Britt GC; McCance-Katz EF Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813 [TBL] [Abstract][Full Text] [Related]
18. 5-methoxy-alpha-methyltryptamine (alphs, o-dimethylserotonin), a hallucinogenic homolog of serotonin. Kantor RE; Dudlettes SD; Shulgin AT Biol Psychiatry; 1980 Apr; 15(2):349-52. PubMed ID: 7417623 [No Abstract] [Full Text] [Related]
19. Human hallucinogenic drug research: regulatory, clinical, and scientific issues. Strassman RJ NIDA Res Monogr; 1994; 146():92-123. PubMed ID: 8742796 [No Abstract] [Full Text] [Related]
20. [Study of the neurologic and psychopathologic effects of a new drug with psychotomimetic action (JB-329 or Ditran) in depressed patients]. GIBERTI F; ROCCATAGLIATA G; ROSSI R Sist Nerv; 1961; 13():167-75. PubMed ID: 13898382 [No Abstract] [Full Text] [Related] [Next] [New Search]